reported. 8 To date, however, chimerism of CSF mononuclear cells after BMT has not been systematically studied. In this study we have evaluated donor-recipient To evaluate the chimeric status of mononuclear cells in the CSF after allogeneic BMT, cells were analyzed by chimerism on the CSF cells in pediatric ALL patients who underwent sex-mismatch allo-BMT with TBI regimens. FISH using satellite DNA probes for human X and Y chromosomes. CSF cells were obtained from five pediatric ALL patients who received BMT from sexmismatched donors. All patients received TBI-containPatients and methods ing conditioning regimens. We found that CSF cells showed complete donor type in 19-97 days after BMT,
for three cases, TBI gens, HLA type, and DNA polymorphisms. 1 The fluor-12 Gy/Ara-C 18 g/m 2 for one case, and TBI 12 Gy/CY escence in situ hybridization (FISH) technique, using sex 120 mg/kg for one case. The number of transfused bone chromosome-specific probes, is a simple and quantitative marrow cells was 3.4-9.0 × 10 8 /kg. GVHD prophylaxis way to detect mixed chimerism following sex-mismatched was CsA alone in two cases, and CsA and short course BMT, particularly in cases where small samples for exam-MTX in three cases. ination are available. Although there have been several
Chromosome analysis on bone marrow cells was perforrefined studies on this issue, they were mostly carried out med with a routine G-banding technique or by FISH before, on peripheral blood cells, or bone marrow cells. [2] [3] [4] [5] and 19-31 days after BMT. Recently, it was reported that there exists great disparity on the chimeric status between peripheral blood cells and FISH analysis on CSF mononuclear cells tissue leukocytes.
6,7 Twenty-five to 100% of alveolar macrophages were of recipient origin about a month after Repeat lumbar punctures were performed to examine CNS allo-BMT, and 25-40% of intestinal mucosal mononuclear relapse and chimeric status 19-97 days after BMT. cells were still recipient in type even 6 months after allo-FISH analysis was performed as previously reported. 9 In BMT, when peripheral blood cells were already of donor brief, cytospun CSF cells on a slide glass were fixed with type.
absolute ethanol for 3 min at room temperature, and stored Cerebrospinal fluid (CSF) is another location where leuat −70°C until analysis. Satellite DNA sequences for human kocytes migrate. Changes in the cell and protein content of X (DXZ1) and Y (DYZ1) chromsome (Oncor, Gaithersthe CSF following allo-BMT have been previously burg, MD, USA) were used as FISH probes. Digoxigeninlabeled DXZ1 probe was detected with mouse anti-digoxin (Sigma, St Louis, MO, USA), rabbit anti-mouse IgG-tetra- (Vector Laboratories, Burlingame, CA, USA), biotinylated results, the level of residual recipient cells within the CSF seemed somewhat higher (1.4-3.6% in the CSF vs 0.0-goat anti-avidin, and a second layer of avidin-FITC. The nuclei were counterstained with DAPI in antifade solution 0.7% in the bone marrow); its significance is unclear, because the difference was within the sensitivity limit of (Vectashield; Vector Laboratories). Cells (92-200) were observed and scored under a fluorescence microscope this method. (Olympus BH2-RFC; Olympus, Tokyo, Japan) using a triple band pass filter. The sensitivity and specificity of the male and female genotype detection with this method was Discussion Ͼ95% of cells from a normal male were correctly identified as male and Ͼ95% of cells from a normal female were
The main purpose of this study was to determine how soon donor-derived mononuclear cells will cross the blood-brain correctly identified as female.
barrier (BBB) and migrate into the CNS in human beings. It was reported that CSF enzyme activity in the patients with lysozomal storage diseases affecting the CNS was corResults rected after allo-BMT. 10,11 More directly, donor-type karyotype was demonstrated in CSF leukocytes from a patient Engraftment was prompt in every case. Neutrophils recovered to more than 0.5 × 10 9 /l by days 10-21. Acute GVHD with metachromatic leukodystrophy 6 months after BMT conditioned with a TBI regimen. 12 These observations indideveloped in four of the five cases: grade I in two cases, grade III in one case, and grade IV in one case. Acute cate that engrafted donor-derived mononuclear leukocytes must enter into the CNS following allo-BMT. To date, GVHD was overcome by adding high-dose methyl prednisolone, or substituting FK506 for CsA. None of these however, it has not been reported how soon donor leukocytes appear in CSF. Unlike tissue macrophages or lymphopatients showed CNS symptoms or abnormal brain MRI after BMT.
cytes, 6,7 we found that CSF mononuclear cells demonstrated complete donor type, when bone marrow cells also In lumbar punctures performed 19-97 days after BMT, CSF cell counts were slightly elevated in two cases showed a complete donor chimerism. According to a review on CSF cell kinetics, the (Table 2) ; however, neither CSF protein and glucose, nor abnormal leukemic cell infiltration was found. migration rate of mononuclear cells into the CSF is extremely low under normal conditions. 13 However, the Detection of donor-recipient cell chimerism by FISH revealed more than 95% of CSF cells were of donor type BBB becomes permeable and leukocytes enter into the brain with ease under pathologic conditions such as menin- (Table 2 ). Chromosome analysis on bone marrow cells also showed a complete donor chimerism by days 17-31 after gitis. In the present study all the patients received 12 Gy TBI-containing conditioning regimens. Animal experiments BMT. Therefore, donor-type leukocytes were considered to enter into the CNS as a result of the engraftment of donor showed local vessel impairment with disruption of the BBB at the site of X-ray irradiation. 14 Altered vascular perhematopoietic cells. Compared with the bone marrow 505 Table 2 Result of chimerism analysis on CSF and bone marrow cells allo-BMT compared to the patients following auto-BMT. 
